De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Ambu Beheer

Beheer criteriumcontroles 3/4

De CEO Ambu's is Britt Jensen, benoemd in May2022, heeft een ambtstermijn van 2.42 jaar. De totale jaarlijkse vergoeding van { bedraagt DKK 18.50M, bestaande uit 40% salaris en 60% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.017% van de aandelen van het bedrijf, ter waarde DKK 5.89M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.8 jaar en 3.8 jaar.

Belangrijke informatie

Britt Jensen

Algemeen directeur

DKK 18.5m

Totale compensatie

Percentage CEO-salaris	40.0%
Dienstverband CEO	2.4yrs
Eigendom CEO	0.02%
Management gemiddelde ambtstermijn	1.8yrs
Gemiddelde ambtstermijn bestuur	3.8yrs

Recente managementupdates

Recent updates

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Jan 02

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Oct 31

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 22

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Aug 19

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Jul 12

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Jun 22

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

May 07

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Mar 24

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Jan 20

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

Dec 08

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Sep 23

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 08

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Aug 21

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Jun 06

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

May 19

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Jan 23

Are Investors Undervaluing Ambu A/S (CPH:AMBU B) By 27%?

Dec 12

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Oct 04

Analyse CEO-vergoeding

Hoe is Britt Jensen's beloning veranderd ten opzichte van Ambu's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	DKK 450m
Mar 31 2024	n/a	n/a	DKK 367m
Dec 31 2023	n/a	n/a	DKK 238m
Sep 30 2023	DKK 19m	DKK 7m	DKK 168m
Jun 30 2023	n/a	n/a	-DKK 42m
Mar 31 2023	n/a	n/a	-DKK 65m
Dec 31 2022	n/a	n/a	DKK 95m
Sep 30 2022	DKK 4m	DKK 3m	DKK 93m
Jun 30 2022	n/a	n/a	DKK 222m
Mar 31 2022	n/a	n/a	DKK 256m
Dec 31 2021	n/a	n/a	DKK 176m
Sep 30 2021	DKK 467k	n/a	DKK 247m
Jun 30 2021	n/a	n/a	DKK 251m
Mar 31 2021	n/a	n/a	DKK 281m
Dec 31 2020	n/a	n/a	DKK 290m
Sep 30 2020	DKK 315k	n/a	DKK 241m

Compensatie versus markt: De totale vergoeding ($USD 2.71M ) Britt } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Danish markt ($USD 2.91M ).

Compensatie versus inkomsten: De vergoeding van Britt is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Britt Jensen (51 yo)

2.4yrs

Tenure

DKK 18,503,000

Compensatie

Ms. Britt Meelby Jensen serves as a Board Member and Advisory Group Member at Novo Holdings A/S. She serves as Director of Hempel A/S since 2024. She is Member of the Board since 2022.She is Chief Executi...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Britt Jensen	Chief Executive Officer	2.4yrs	DKK 18.50m	0.017% DKK 5.9m
Holger Hesse	Founder	no data	geen gegevens	geen gegevens
Henrik Bender	Executive VP & CFO	less than a year	geen gegevens	geen gegevens
Henrik Birk	Chief Operations Officer	1.8yrs	geen gegevens	geen gegevens
Finn Mohring	Chief Technology Officer	1.2yrs	geen gegevens	geen gegevens
Nicolai Thomsen	Director of Investor Relations & Strategic Financial Planning	no data	geen gegevens	geen gegevens
Mikkel Wagner	Director of Corporate Communications	no data	geen gegevens	geen gegevens
Rummana Hasan	Chief Marketing Officer	less than a year	geen gegevens	geen gegevens
Thomas Henriksen	Head of HR Systems	no data	DKK 72.00k	geen gegevens
Måns Barsne	Executive VP of Global Innovation & Chief Innovation Officer	9.8yrs	geen gegevens	geen gegevens
Bassel Rifai	President of APAC	no data	geen gegevens	geen gegevens
Sanne Hjordrup	Senior Vice President of People & Culture	2.8yrs	geen gegevens	geen gegevens

1.8yrs

Gemiddelde duur

50.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van AMBU B wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.8 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Christian Sagild	Independent Director	12.8yrs	DKK 934.00k	0.096% DKK 33.0m
Michael J. Del Prado	Independent Director	2.8yrs	DKK 842.00k	0.00038% DKK 130.9k
Shacey Petrovic	Independent Vice Chairman of the Board	2.8yrs	DKK 492.00k	0.0021% DKK 716.7k
Susanne Larsson	Independent Director	2.8yrs	DKK 844.00k	0.00038% DKK 130.9k
Simon Hoffmann	Independent Director	2.8yrs	DKK 372.00k	2.89% DKK 996.3m
Jorgen Jensen	Independent Chairman of the Board	5.8yrs	DKK 1.52m	0.0061% DKK 2.1m
Thomas Jensen	Employee Representative Director	3.8yrs	DKK 350.00k	0.00057% DKK 196.4k
Charlotte Bjornhoff	Employee Representative Director	3.8yrs	DKK 350.00k	0.00034% DKK 117.2k
Jesper Mads Frederiksen	Employee Representative Director	3.8yrs	DKK 350.00k	0.00064% DKK 220.5k

3.8yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van AMBU B wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).

Ambu Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Ambu A/S, Annual General Meeting, Dec 03, 2025

Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors

Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors

Ambu A/S Appoints Henrik Skak Bender as Member of the Executive Management, Effective 1 January 2024

Ambu A/S Announces Chief Financial Officer Changes

High number of new directors

Recent updates

Ambu A/S, Annual General Meeting, Dec 03, 2025

Ambu A/S to Report Q1, 2025 Results on Jan 30, 2025

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Third quarter 2024 earnings: EPS exceeds analyst expectations

Price target increased by 8.1% to kr.123

Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Consensus EPS estimates increase by 14%

Second quarter 2024 earnings: EPS misses analyst expectations

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

First quarter 2024 earnings released

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Price target increased by 10% to kr.101

Price target increased by 7.2% to kr.91.83

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors

Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Price target decreased by 9.0% to kr.87.00

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Ambu A/S Appoints Henrik Skak Bender as Member of the Executive Management, Effective 1 January 2024

Ambu A/S Announces Chief Financial Officer Changes

Ambu A/S to Report Q2, 2024 Results on May 14, 2024

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23

Third quarter 2023 earnings released

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

New minor risk - Share price stability

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

Second quarter 2023 earnings: Revenues in line with analyst expectations

Price target decreased by 8.7% to kr.95.50

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Consensus EPS estimates fall by 15%

Consensus EPS estimates increase by 14%

Price target increased by 16% to kr.96.80

First quarter 2023 earnings released: EPS: kr.0.09 (vs kr.0.08 in 1Q 2022)

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

Full year 2022 earnings: Revenues in line with analyst expectations

Consensus forecasts updated

Ambu A/S to Report Q3, 2023 Results on Aug 31, 2023

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Ambu A/S(CPSE:AMBU B) dropped from FTSE All-World Index (USD)

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Now 20% undervalued after recent price drop

Price target decreased to kr.76.50

Third quarter 2022 earnings: Revenues in line with analyst expectations

Ambu A/S Reaffirms Earnings Guidance for the Full-Year 2021/2022

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Consensus forecasts updated

Ambu A/S Revises Earnings Guidance for the Full-Year 2021/2022

Ambu Announces FDA Clearance of Fifth-Generation Single-Use Bronchoscope

Investor sentiment deteriorated over the past week

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Price target decreased to kr.94.25

Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021/22

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

Consensus forecasts updated

Second quarter 2022 earnings: Revenues in line with analyst expectations

Price target decreased to kr.137

Less than half of directors are independent